cfDNA methylome profiling for detection and subtyping of small cell lung cancers

[1]  G. Fan,et al.  DNA methylation in small cell lung cancer , 2023, Clinical and Translational Discovery.

[2]  C. Swanton,et al.  Clinical validation of a targeted methylation-based multi-cancer early detection test using an independent validation set. , 2021, Annals of oncology : official journal of the European Society for Medical Oncology.

[3]  C. Rudin,et al.  Small-cell lung cancer: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up†. , 2021, Annals of oncology : official journal of the European Society for Medical Oncology.

[4]  Liang Wang,et al.  Cell-free DNA methylome profiling by MBD-seq with ultra-low input , 2021, Epigenetics.

[5]  W. Klepetko,et al.  Molecular profiles of small cell lung cancer subtypes: therapeutic implications , 2021, Molecular therapy oncolytics.

[6]  P. Robson,et al.  Patterns of transcription factor programs and immune pathway activation define four major subtypes of SCLC with distinct therapeutic vulnerabilities. , 2021, Cancer cell.

[7]  P. Meltzer,et al.  SCLC-CellMiner: A Resource for Small Cell Lung Cancer Cell Line Genomics and Pharmacology Based on Genomic Signatures , 2020, Cell reports.

[8]  C. Rudin,et al.  Small Cell Lung Carcinoma Subtypes Defined by ASCL1, NEUROD1, POU2F3 and YAP1: Comprehensive Immunohistochemical and Histopathologic Characterization. , 2020, Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer.

[9]  C. Dive,et al.  The Rare YAP1 Subtype of SCLC Revisited in a Biobank of 39 Circulating Tumor Cell Patient Derived Explant Models: A Brief Report , 2020, Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer.

[10]  Keegan D. Korthauer,et al.  Detection of renal cell carcinoma using plasma and urine cell-free DNA methylomes , 2020, Nature Medicine.

[11]  K. Aldape,et al.  Detection and discrimination of intracranial tumors using plasma cell-free DNA methylomes , 2020, Nature Medicine.

[12]  Gabor Marth,et al.  MYC Drives Temporal Evolution of Small Cell Lung Cancer Subtypes by Reprogramming Neuroendocrine Fate. , 2020, Cancer cell.

[13]  L. Girard,et al.  A biobank of small cell lung cancer CDX models elucidates inter- and intratumoral phenotypic heterogeneity , 2020, Nature Cancer.

[14]  P. Robson,et al.  Single-cell analyses reveal increased intratumoral heterogeneity after the onset of therapy resistance in small-cell lung cancer , 2020, Nature Cancer.

[15]  M. Krasnow,et al.  New approaches to small cell lung cancer therapy : from the laboratory to the clinic. , 2020, Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer.

[16]  Crispin J. Miller,et al.  Profiling of Circulating Free DNA Using Targeted and Genome-wide Sequencing in Patients with SCLC , 2020, Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer.

[17]  Anshul Kundaje,et al.  The ENCODE Blacklist: Identification of Problematic Regions of the Genome , 2019, Scientific Reports.

[18]  Nicholas T. Ingolia,et al.  MYC-Driven Small-Cell Lung Cancer is Metabolically Distinct and Vulnerable to Arginine Depletion , 2019, Clinical Cancer Research.

[19]  G. Giaccone,et al.  Surgical Resection of SCLC: Prognostic Factors and the Tumor Microenvironment , 2019, Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer.

[20]  C. Rudin,et al.  Molecular subtypes of small cell lung cancer: a synthesis of human and mouse model data , 2019, Nature Reviews Cancer.

[21]  G. Troncone,et al.  Liquid Biopsy and Lung Cancer , 2018, Acta Cytologica.

[22]  Nam-Trung Nguyen,et al.  DNA methylation detection: recent developments in bisulfite free electrochemical and optical approaches. , 2018, The Analyst.

[23]  A. Mansfield,et al.  First‐Line Atezolizumab plus Chemotherapy in Extensive‐Stage Small‐Cell Lung Cancer , 2018, The New England journal of medicine.

[24]  C. Dive,et al.  Will liquid biopsies improve outcomes for patients with small-cell lung cancer? , 2018, The Lancet. Oncology.

[25]  S. Wingett,et al.  FastQ Screen: A tool for multi-genome mapping and quality control , 2018, F1000Research.

[26]  D. Spector,et al.  POU2F3 is a master regulator of a tuft cell-like variant of small cell lung cancer , 2018, Genes & development.

[27]  Dianne Cook,et al.  plyranges: a grammar of genomic data transformation , 2018, Genome Biology.

[28]  J. Minna,et al.  Small-cell lung cancer: what we know, what we need to know and the path forward , 2017, Nature Reviews Cancer.

[29]  Nikhil Wagle,et al.  Scalable whole-exome sequencing of cell-free DNA reveals high concordance with metastatic tumors , 2017, Nature Communications.

[30]  Jing Wang,et al.  Protein expression of TTF1 and cMYC define distinct molecular subgroups of small cell lung cancer with unique vulnerabilities to aurora kinase inhibition, DLL3 targeting, and other targeted therapies , 2017, Oncotarget.

[31]  Marek Dynowski,et al.  Next-Generation Sequencing Analysis and Algorithms for PDX and CDX Models , 2017, Molecular Cancer Research.

[32]  Paolo Di Tommaso,et al.  Nextflow enables reproducible computational workflows , 2017, Nature Biotechnology.

[33]  K. Garcia,et al.  Intratumoral heterogeneity generated by Notch signaling promotes small cell lung cancer , 2017, Nature.

[34]  Peter J. Park,et al.  NGSCheckMate: software for validating sample identity in next-generation sequencing studies within and across data types , 2017, Nucleic acids research.

[35]  C. Rudin,et al.  Chemosensitive Relapse in Small Cell Lung Cancer Proceeds through an EZH2-SLFN11 Axis. , 2017, Cancer cell.

[36]  Kristofer C. Berrett,et al.  MYC Drives Progression of Small Cell Lung Cancer to a Variant Neuroendocrine Subtype with Vulnerability to Aurora Kinase Inhibition. , 2017, Cancer cell.

[37]  H. Sültmann,et al.  QSEA—modelling of genome-wide DNA methylation from sequencing enrichment experiments , 2016, Nucleic acids research.

[38]  A. Monks,et al.  Small Cell Lung Cancer Screen of Oncology Drugs, Investigational Agents, and Gene and microRNA Expression. , 2016, Journal of the National Cancer Institute.

[39]  Måns Magnusson,et al.  MultiQC: summarize analysis results for multiple tools and samples in a single report , 2016, Bioinform..

[40]  A. Heger,et al.  UMI-tools: modeling sequencing errors in Unique Molecular Identifiers to improve quantification accuracy , 2016, bioRxiv.

[41]  Ana Conesa,et al.  Qualimap 2: advanced multi-sample quality control for high-throughput sequencing data , 2015, Bioinform..

[42]  Qing-Yu He,et al.  ChIPseeker: an R/Bioconductor package for ChIP peak annotation, comparison and visualization , 2015, Bioinform..

[43]  Matthew E. Ritchie,et al.  limma powers differential expression analyses for RNA-sequencing and microarray studies , 2015, Nucleic acids research.

[44]  W. Huber,et al.  Moderated estimation of fold change and dispersion for RNA-seq data with DESeq2 , 2014, Genome Biology.

[45]  Elodie Portales-Casamar,et al.  Meta-analysis of human methylomes reveals stably methylated sequences surrounding CpG islands associated with high gene expression , 2014, Epigenetics & Chromatin.

[46]  Tao Wang,et al.  ASCL1 is a lineage oncogene providing therapeutic targets for high-grade neuroendocrine lung cancers , 2014, Proceedings of the National Academy of Sciences.

[47]  Mahmood Ayub,et al.  Tumorigenicity and genetic profiling of circulating tumor cells in small-cell lung cancer , 2014, Nature Medicine.

[48]  Ralf Herwig,et al.  MEDIPS: genome-wide differential coverage analysis of sequencing data derived from DNA enrichment experiments , 2013, Bioinform..

[49]  E. Felip,et al.  Small-cell lung cancer: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up. , 2010, Annals of oncology : official journal of the European Society for Medical Oncology.

[50]  Gonçalo R. Abecasis,et al.  The Sequence Alignment/Map format and SAMtools , 2009, Bioinform..

[51]  Kevin P. Murphy,et al.  Integrating copy number polymorphisms into array CGH analysis using a robust HMM , 2006, ISMB.

[52]  Tom H. Pringle,et al.  The human genome browser at UCSC. , 2002, Genome research.

[53]  G. Kalemkerian,et al.  Small cell lung cancer , 2010, Seminars in Respiratory and Critical Care Medicine.

[54]  J. Minna,et al.  Characterization of variant subclasses of cell lines derived from small cell lung cancer having distinctive biochemical, morphological, and growth properties. , 1985, Cancer research.